A Single Site, Phase 2B, Randomized, Double-Blind, Study to Assess the Efficacy, Safety, and Tolerability of Twice Daily Oral ALLOD-2 vs. Placebo in the Treatment of Chronic Low Back Pain (ANODYNE-4)
Phase of Trial: Phase II/III
Latest Information Update: 24 Jun 2019
Price : $35 *
At a glance
- Drugs ALLOD 2 (Primary)
- Indications Back pain
- Focus Proof of concept; Registrational; Therapeutic Use
- Acronyms ANODYNE-4
- Sponsors Allodynic Therapeutics
- 20 Jun 2019 Status changed from active, no longer recruiting to completed.
- 14 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 29 Oct 2017 Planned number of patients changed from 48 to 12.